N-ε-Boc-L-lysine 4-nitroanilide is a Boc-protected L-lysine derivative in which the ε-amino group is converted to a 4-nitroanilide while the α-amino and α-carboxyl functionalities remain part of the lysine backbone. The molecule contains a tert-butoxycarbonyl (Boc) protecting group on the ε-nitrogen, a carboxamide linkage to 4-nitroaniline, and the characteristic lysine side chain bearing a terminal substituted amide rather than a free primary amine, with stereochemistry indicated as L at the α-carbon. In peptide chemistry and related synthesis, this protected amino acid amide functions as a protected lysine building block for preparing peptide or peptide-like intermediates and for introducing a nitroanilide-containing side-chain handle used in labeling, analytical readouts, or structure-activity studies.
CAT No: CP01474
CAS No:172422-76-3
Synonyms/Alias:172422-76-3;H-LYS(BOC)-PNA;H-L-Lys(Boc)-pNA;(S)-tert-Butyl(5-amino-6-((4-nitrophenyl)amino)-6-oxohexyl)carbamate;AmbotzHAA1183;AC1OLRCK;N-e-Boc-L-lysine4-nitroanilide;CTK8E9396;MolPort-008-267-983;C17H26N4O5;N-|A-Boc-L-lysine4-nitroanilide;ZINC4899673;7197AH;AKOS022181120;AM81967;AJ-52580;AK-63458;RT-013210;FT-0697819;ST24036402;K-5295;tert-butylN-[(5S)-5-amino-6-(4-nitroanilino)-6-oxohexyl]carbamate
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.